Find an expert

PLEASE NOTE THAT ANY AUTHORSHIP ALTERATIONS LISTING ME AS SIMPSON-FRASER BELOW ARE INCORRECT. ALL PUBLICATIONS ARE FIONA SIMPSON. MY PROFESSIONAL NAME IS FIONA SIMPSON.

https://www.abc.net.au/radionational/programs/ockhamsrazor/the-tricky-business-of-cancer-research/9498246

Our laboratory is involved in cross-discipline research studying endocytosis, cancer, pharmacology and immunology to improve therapies used in cancer treatment.

Peter holds a BSc Honours degree and a PhD in Molecular Biology from the University of Liverpool in the UK. His first postdoctoral research position was at the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research, London UK. He moved to Australia in 2005 and helped Professor Lakhani establish the Molecular Breast Pathology research group and the Brisbane Breast Bank. He is a member of the International Cancer Genome Consortium (Breast Cancer group) and is a Fellow of the Faculty of Science in the Royal College of Pathologists of Australasia. He holds a joint teaching and research position at UQ, teaching for the Discipline of Pathology on the Faculty of Medicine MD Program and is the Head of the Cancer Theme and Research Group Leader in Cancer Genomics at the UQCCR.

Professor Peter Sly is the Director, Children's Health and Environment Program. Professor Sly is a NHMRC Leadership Fellow (L3) and an emeritus paediatric respiratory physician with extensive research experience in respiratory physiology, developmental immunology and children's environmental health. Professor Sly’s research aims to understand the mechanisms underlying chronic childhood lung diseases in order to improve clinical management and to delay or prevent their onset, with consequent reductions in adult lung diseases. A combination of basic science, longitudinal cohort studies and translation of research findings into clinical practice, including clinical trials, are included in three main areas: asthma, cystic fibrosis and children’s environmental health

Professor Sly is an advisor to the World Health Organisation Department of Public Health, Environmental and Social Determinants of Disease and currently serves on International Advisory Boards and committees, including: WHO network of Collaborating Centres in Children’s Environmental Health; Canadian Healthy Infant Longitudinal Development (CHILD) Study, Canada; the Infant Lung Health Study, Paarl, South Africa; and A SHARED Future: Achieving Strength, Health, and Autonomy, through Renewable Energy Development for the Future.

My group works to understand and improve sleep for children and families. Sleep is a key ‘pillar of health’ alongside nutrition and activity. It is critical for healthy development, growth, learning, social and emotional functioning, and community participation.

I am the UQ Node Director for the ARC Centre of Excellence for Children and Families over the Life Course (the Life Course Centre). The Life Course Centre is committed to understanding and overcoming the problems of disadvantage, and to helping improve the lives of disadvantaged children and families. The Centre brings together researchers across multiple disciplines in four leading Universities, and significant government and non-government agencies to address these questions.

I am also the UQ Node director for the ARC centre of Excellence for the Digital Child. The Digital Child aims to support children growing up in the rapidly changing digital world, and provide strong evidence and guidance for children, families, educators, government and other concerned with children’s wellbeing.

We collaborate with many other groups around broader issues of sleep and technology, sleep and the environment (including disasters), mental health and wellbeing, pain, disability, and new technologies and approaches. Our work has been supported by the ARC, NHMRC, the MRFF, the NIH, and the DSTG. We use a wide range of methods and measures, including direct physiological and behavioural measurement (inc. ECG, EEG, EMG, actigraphy, computerized tests, simulations, environmental monitoring etc.), quantitative methods (inc. experimental and secondary data approaches), and qualitative methods including co-design and co-conduct approaches.

My team has additional expertise in evaluation of health and other services for government and other agencies, the design of complex interventions, and community consultation and engagement.

https://lifecoursecentre.org.au

https://digitalchild.org.au

Update Profile

Emeritus Professor Maree Smith AC FTSE FAHMS is a full-time researcher and Director, CIPDD, School of Biomedical Sciences, Faculty of Medicine, The University of Queensland.

In the 12 years prior to her current appointment, Professor Smith led a high-performing team in building the CIPDD and its commercial interface TetraQ, recognized as a unique, GLP-accredited drug development Centre in Australia. Professor Smith has considerable expertise in biomedical discovery/translation with specialist expertise in the novel pain therapeutics discovery/translation field encompassing a portfolio of 16 rodent pain models that mimic individual human pain conditions. This portfolio of models conducted in a purpose-built facility operated in accordance with the requirements of our Quality Management System, making the CIPDD unique in Australia and rare internationally.

In the 15 years prior to establishing the CIPDD, Professor Maree Smith was a full-time academic in the School of Pharmacy. In brief, she joined the School of Pharmacy as a Lecturer in 1989 and was successively promoted through the academic ranks to Professor in 2004. Prior to that she undertook a PhD and early postdoctoral training in clinical pharmacology with specialist expertise in bioanalytical method development, bioanalysis of human plasma samples, drug metabolism and clinical pharmacokinetics. Her second postdoc was in the field of pain management and pain pharmacology.

In the years, 1990-2005, Maree Smith taught in the Drug Discovery stream of the 2nd, 3rd & 4th years of the undergraduate Pharmacy program and she was instrumental in developing innovative courses for the final year of the undergraduate Pharmacy curriculum. She was also instrumental in the development of a course for the M Biotech program at UQ entitled “Quality Systems in Biotechnology” which continues to this day and is a compulsory course in the Program. Maree has successfully advised/co-advised to completion 33 PhD students, 2 Research Masters students and ~50 Honours students. She also served for 14 years as an external evaluator for the TGA.

Maree's Current Research Interests are as follows:

1. Subtle differences in the pathobiology of individual chronic pain conditions

2. Improving preclinical to clinical translation in novel analgesics development

3. Preclinical drug development of novel pain therapeutics

4. Preclinical drug development

Awards

2021 UQ Fellowship

2019 Companion of the Order of Australia (AC) in the Queen's Birthday Honours List

2018 Honorary Bragg Membership (The Royal Institution of Australia)

2016 Bowl of Hygeia Award (Pharmaceutical Society of Australia)

2016 Clunies Ross Knowledge Commercialisation Award (ATSE)

2015 Honoured to be included in inaugural list of Australia's top Innovators; viz Knowledge Nation 100

2015 Inaugural Inductee into the Life Sciences Queensland (LSQ) Hall of Fame

2015 Johnson and Johnson Innovaton AusBiotech Industry Excellen Award - Outstanding Leader category.

2015 Elected Fellow, Australian Academy of Health and Medical Sciences (AAHMS)

2015 Australian Pain Society Distinguished Member Award - For services to the promotion, treatment and science of pain management and lifelong contribution to the Australian Pain Society

2013 UQ Top 5 Inventor - Award by Thomson Reuters and UQ at inaugural Awards

2013 UQ Top 5 Innovator - Award by UniQuest Pty Ltd and UQ at inaugural Awards

2012 Queensland Life Sciences Industry Excellence Award jointly with Dr Jim Aylward

2011 Elected Fellow, Australian Academy of Technological Sciences (ATSE)

2009 Honorary Fellowship, Faculty of Pain Medicine, ANZCA (Australian and New Zealand College of Anaesthetists).

2008 WiT (Women in Technology): Biotech Outstanding Achievement Award

2002 Meritorious Mention for Sustained Excellence in Research Higher Degree Supervision

2001 Meritorious Mention for Sustained Excellence in Research Higher Degree Supervision

Michelle Smith is a Associate Professor in Physiotherapy and a Titled Sports and Exercise Physiotherapist. She is Program Director for the Masters of Sports Physiotherapy and Masters of Musculoskeletal Physiotherapy programs at UQ, Co-director of the International Ankle Consortium, Co-director of the Sports Injury Rehabilitation and Prevention for Health (SIRPH) research unit and Associate Editor of Physical Therapy and Sport.

The overarching theme of Michelle's research is lower limb joint health. Her research focuses on the prevention and management of lower limb joint injuries and pathologies across the lifespan to enable unrestricted participation in sport, physical activity and work. There are three key areas of her research:

1. To improve understanding of ankle injuries and osteoarthritis across the lifespan: Ankle sprains are the most common injury seen in emergency departments and are a primary cause of ankle osteoarthritis, which in light of its post-traumatic nature, often affects young adults. To optimise outcomes and participation for people with ankle pathologies, my research characterises impairments and participation restrictions in the continuum from ankle injury to osteoarthritis and establishes the efficacy of interventions to manage these conditions.
2. To understand the effectiveness and implementation of injury prevention strategies: While neuromuscular exercise program and taping/bracing have been shown to decrease injury risk, translation of research into practice is limited. My research investigates the implementation of injury prevention initiatives in adolescent athletes and involves stakeholders to better understand barriers and facilitators.
3. To evaluate the implementation of lower limb osteoarthritis interventions: Exercise and education for hip and knee osteoarthritis have been shown to improve quality of life and functional outcomes. My research investigates the implementation of such programs in public hospitals and private physiotherapy practices on patient outcomes and service delivery.

Michelle has presented her research and delivered keynote and invited presentations at national and international multi-disciplinary conferences. She teaches across the undergraduate and postgraduate physiotherapy curriculum in the areas of musculoskeletal health and sports injuries. She has been recognised for her high teaching quality and impact at both School and Faculty levels through receipt of Teaching Excellence Awards. She is the Chair of the School of Health and Rehabilitation Sciences External Engagement Committee and Deputy Chair of the Sports and Exercise Physiotherapy Group of the Austrailan Physiotherapy Association. She is a member of the Outcome Measures in Rheumatology (OMERACT) Foot and Ankle Working Group, International Foot and Ankle Osteoarthritis Consortium, and Australian Foot and Ankle Research Network.

Dr. Alex Smith is a Research Fellow in Glycotherapeutics at UQ's School of Chemical Engineering. His interests are in understanding structure: function relationships between complex carbohydrates (such as heparan sulphate) and proteins, and how these interactions can inform the development of glycotherapeutic agents to treat a wide variety of injuries and diseases.

Professor Anthony Smith is the Director of The University of Queensland’s Centre for Online Health (COH), and Adjunct Professor at the Hans Christian Anderson Children's Hospital and University of Southern Denmark, in Odense, Denmark.

Professor Smith is also the Editor in Chief for the Journal of Telemedicine and Telecare (Sage Publishers, London; 5y Impact Factor 4.9).

Professor Smith has more than 25 years of research experience, resulting in the planning, implementation and evaluation of a broad range of telehealth (virtual care) services around Australia. Specific research interests include the feasibility, effectiveness and sustainability of telehealth services in the public health system; genuine consumer engagement; and novel strategies to support our health workforce and telehealth adoption. His research has led to the development of pioneering virtual care services in Australia, including prominent statewide hospital-based telehealth programs in Queensland, wireless (robot) videoconference systems for remote consultations; and a community-based (and telehealth supported) health screening programme for Indigenous children in Queensland. Current projects focus on the integration of telehealth and virtual care services in residential aged care settings; evaluation of community-led First Nations health services; the delivery of video-based rehabilitation services to children in rural and remote primary schools; telementoring services for health professionals in primary care; and discipline specific clinical telehealth services.

Professor Smith chairs the International Conference on Successes and Failures in Telehealth conference. He is also a Fellow of the Queensland Academy of Arts and Sciences. Previous roles have included the President of the Australasian Telehealth Society (ATHS) [2013-2015]; and elected member of the ATHS committee [2008-2024]. In the field of telehealth and virtual care, Prof Smith has over 240 publications, including 230 peer-reviewed journal papers, three edited books and 13 book chapters on related topics. Whilst the field remains highly specialised in comparison to other disciplines, his work is cited over 2000 times each year.

Professor Smith also provides an extensive range of consultancy services for government agencies and industry partners in the field of telehealth, digital health and virtual healthcare.

Recent Awards:

1. Public Engagement and Community-led Research (including Citizen Science) Award, The University of Queensland Research Culture Awards, 2024.

2. Top Researcher in the field of "Medical Informatics"- for work involving telehealth, digital health and virtual care. The Australian Research Awards, 2023

3. Commendation, Academic Leader of the Year, UQ Faculty of Medicine Excellence Awards, The University of Queensland, 2023

4. Excellence in Indigenous Engagement Award - for "enhancing access to specialist health services through the use of telehealth for First Nations people. Engagement Australia Excellence Awards, 2021

5. Spirit of Reconciliation Award - for building research and community partnerships in Queensland. UQ Faculty of Medicine Excellence Awards, The University of Queensaland, 2021

Dr Smith is an early career researcher and Registrar in Intensive Care Medicine at RBWH and Mater Hospitals. Despite being at an early stage in his medical and research career, Sam has already gained valuable experience and enthusiasm in medical education and research, crossing clinical and methodological domains.

Dr Smith gained his primary medical qualification at James Cook University, graduating in 2019 with Honours and awards in research/ Evidence Based Medicine, rural medicine, and with the Dr D. Graham Prize for the highest marks in surgical examinations. His Honours research, supervised by Professor Jonathan Golledge, focussed on the economic impacts of readmission after surgery for peripheral artery disease (PAD). For this research, he was awarded the Professor Philip Walker Scholarship in Vascular Research, allowing him to present his findings internationally. He has co-authored papers in vascular and cardiothoracic surgery, tropical infectious diseases, and care of critically unwell and trauma patients.

Aside from clinical duties, Sam is also active in teaching, guest lecturing at James Cook University and the University of Queensland, as well as teaching medical students in the clinical setting. In his clinical practice, Sam has developing interests in critical care medicine, vascular access, POCUS and incorporating best evidence into daily practice. His committment to teaching, research and governance led to Dr Smith being awarded the CPMEC QLD Junior Doctor of the Year Award in 2021. Sam is always very keen to share his enthusiasm for all things evidence-based with students or really anyone who will listen.

Qualifications

• MBBS (Hons.)
• MPH&TM

I am a senior researcher with cross-disciplinary expertise in health economics, pharmacy practice, and virtual health solutions. I am passionate about optimising healthcare outcomes by developing economically sustainable services that use technology and artificial intelligence to empower patients. My work explores the economic efficiency of implementing either virtual health or advanced-scope clinician initiatives within the Australian health system to improve patient care.

I am also a clinical pharmacist with more than a decade of experience in patient care and clinician training. I am a health economist at the UQ School of Pharmacy and Phamaceutical Sciences, and I lead the research work in the Pharmacy Department at the Princess Alexandra Hospital in Brisbane.

Professor Soyer is an academic dermatologist with over 30 years experience in the field. He was appointed as the inaugural Chair in Dermatology by The University of Queensland (UQ) in 2007 and was Director of the Princess Alexandra Hospital (PAH) Dermatology Department from 2008-2023. His clinical background drives a strong focus on translational skin cancer research.

Professor Soyer is internationally recognised in the field of dermatology with particular expertise in the areas of preventative dermatooncology, dermatopathology and dermatologic imaging (dermoscopy and reflectance confocal microscopy). Within the dermatology discipline he is a pioneer and world leader in the field of dermoscopy of pigmented skin lesions, a non-invasive diagnostic method. He has led the development of the morphologic classification system currently used worldwide.

His main research focus is skin cancer (both melanoma and keratinocyte skin cancer), with a particular interest in technological innovations and their ability to impact early detection strategies and expand the concept and applications of teledermatology and teledermoscopy. A $9.9M infrastructure grant awarded in 2018 by the Australian Cancer Research Foundation (ACRF) has enabled establishment of the collaborative Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID); installing 15 3D total body imaging systems, linked by a research network, across Australia’s east cost to facilitate research in the early detection of melanoma. ACRF ACEMID is currently conducting Australia’s largest melanoma cohort study targeting 15,000 participants, with the multi-modal research data being collected and stored in a national research repository. This unprecedented data resource will allow many unanswered research questions in the field to be addressed and will facilitate advancements in artificial intelligence, resulting in the development of reliable, evidence-based solutions to transform melanoma early detection.

Professor Soyer has an extensive publication record with over 680 publications to date, with more than 700 citations per year (in the last 5 years) and an h-index of 96 (Google Scholar). His textbook entitled "Dermoscopy - The Essentials 3rd Edition", co-authored with G Argenziano, R Hofmann-Wellenhof and I Zalaudek is considered a world-leading textbook in the field.

Professor Soyer has been awarded two competitive fellowships while at UQ: a Medical Research Future Fund (MRFF) Next Generation Clinical Researchers Program Practitioner Fellowship (2018-2022) and an NHMRC Practitioner Fellowship (2012-2016). The NHMRC Practitioner Fellowship was acknowledged in the NHMRC ‘10 of the Best NHMRC research projects 2016’ publication. He has also been awarded 1 NHMRC European Union Collaborative Research Grant (CIA), 1 NHMRC Synergy Grant (CIC), 1 NHMRC Clinical Trials and Cohort Studies Grant (CIC), 1 MRFF Targeted Health System and Community Organisation Research Grant (CIC), 3 NHMRC Centre of Research Excellence Grants (CIA, CIB, CIE), 4 NHMRC Project Grants (CIA, CIA, CIB, CID), 2 NHMRC Partnership Grants (CIA, CIB), 2 ARC Discovery Project Grants (CIB, CID), and a Queensland Genomic Health Alliance (QGHA) Demonstration Project Grant (CIA), with many additional projects funded through other competitive, industry and philanthropic funding sources. In total, through his involvement as an investigator, he has achieved over $43M in research funding for UQ since 2014.

Associate Professor Spurling works at The University of Queensland General Practice Clinical Unit (0.4 FTE) and at the Southern Queensland Centre of Excellence in Aboriginal and Torres Strait Islander primary health care (Inala COE – 0.6 FTE). He has research interests in social determinants of health and access to primary health care, especially where his research skills can be of service to Aboriginal and Torres Strait Islander peoples. His other research interests are quality use of medicines and respiratory infections, with particular methodological interests in systematic reviews and mixed-methods research in general practice. His most recent research interest concerns access to opioid dependence treatment in general practice.

He completed medical training at the University of Queensland, did his junior doctor years in regional Queensland and completed a Diploma of Tropical Medicine and Hygiene in London in 1998. In 2001, he spent 12 months working on a project in Central America with Médecins Sans Frontières. He completed general practice specialty training with the RACGP in 2004, which included an academic registrar term. In 2004, he was fortunate to meet Professor Noel Hayman, one of Queensland’s first Aboriginal medical graduates and Clinical Director of the Inala COE, who offered him a GP position in 2004. He has shared his full-time work as a GP academic at the Inala COE and UQ GPCU ever since.

Associate Professor Spurling has developed clinical interests in serving the Aboriginal and Torres Strait Islander community in Inala, serving Spanish-speaking refugees, diabetic retinopathy, and, most recently, addiction medicine. He has been mentoring GP registrars and medical students at the Inala COE since 2004. As a member of the UQ GPCU academic staff, he regularly takes tutorial groups and lectures in cardiovascular medicine, respiratory infections, Aboriginal and Torres Strait Islander health and social determinants of health for medical students doing their general practice rotation.

Associate Professor Spurling supervises five postgraduate students (PhD students). He has been awarded over A$18M in research grants and has published over 80 peer-reviewed papers.

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

• Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
• Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
• Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
• Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
• Improving gentamycin dosing in paediatric oncology patients
• Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
• Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
• Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

• Dose optimisation of busulfan in paediatric bone marrow transplant recipients
• Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
• Examining Bayesian forecasting methods to predict immunosuppressant exposure
• Examining the international use of immunosuppressant and anti-rheumatic drugs
• Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

• PHRM3052- Biological Fate of Drugs

Teaches in:

• PHRM3052- Biological Fate of Drugs
• PHRM3011- Quality Use of Medicines

My work focusses on activation of innate immune cells by pathogen products. Following my PhD at UQ on transcriptional regulation in macrophages I went in 1996 to the University of Cambridge on a CJ Martin Fellowship to work in a molecular parasitology laboratory. I returned to the the University of Queensland in where I focussed on immune cell responses to foreign DNA. I was awarded an ARC Future Fellowship in 2009 to move to the School of Chemistry and Molecular Bioscience, where I also lecture in immunology.

Dr Hana Starobova is a pharmacist and NHMRC research fellow at the Sensory Neuropharmacology Group at the University of Queensland (UQ). She works under the mentorship of Prof. Vetter, and as an early career researcher, she is working toward an independent research career as a group leader. She obtained her PhD in 2020 from the Institute for Molecular Bioscience, UQ, and continued here to conduct studies as a Children Hospital Foundation Fellow (2021-2023) in the areas of cancer therapy-induced adverse and late effects with the main focus on neuropathies. Over the past four years, she has developed a research program focusing on the understanding of cancer therapy-induced adverse and late effects with a special interest in children, and established innovative transcriptomic and microscopy pipelines, in vitro assays, adult and juvenile models of adverse and late effects following mono- and combination chemotherapy and radiotherapy, assays for the assessment of adverse effects including cognition and neuropathies, as well as cancer models. Knowledge impact arising from her research program has been disseminated in 18 peer-reviewed publications, having together attracted >1,100 citations (h-index 15, i10-index 18, Google Scholar, May 2024).

Dr Sally Staton is a Senior Research Fellow in the Science of Learning Research Centre at the Queensland Brain Institute, UQ. Dr Staton has a strong commitment to research that can inform and ensure positive early life experience for all children. Her research focuses on the role of early education and care settings in supporting young children’s immediate and on-going social-emotional, cognitive and physical development. Dr Staton’s research spans a range of study designs and methodologies, including evaluation studies in educational settings (applying randomised control trial and quasi-experimental designs), longitudinal studies tracking large child cohorts (>2000 children), standard observation techniques (in vivo and video), survey and individualised standard child assessment (using educational and psychological measures), as well as studies employing physiological (cortisol, actigraphy, heart rate variability) and qualitative (child, educator and parent interviews, socio-metric) designs. She has a particular expertise in the development, application and interpretation of observational measurement for educational practices and teacher-child interactions in education contexts, including early childhood settings. Dr Staton has a strong track record in research translation and community engagement, including delivery of reports for government and non-government organisations, professional development packages for early childhood professionals and teachers, presentations, workshops, videos and articles for parents, government regulatory officers and the early childhood sector. In 2016, she was named among Queensland’s Young Tall Poppy Scientists for her contribution to science translation and engagement. In 2019 her succesful research partnerships with industry and government was acknowledged in a Partners in Research Excellence Award from UQ.